Novartis is trimming its biomedical research arm. This follows recent staff consolidation moves. A company spokesperson confirmed individual impacts to a select number of employees. This strategic decision is difficult for those affected. Novartis employed 5,720 professionals in this department at the end of 2025.
https://www.fiercebiotech.com/biotech/novartis-cuts-select-number-roles-biomedical-research-arm